Solvonis Therapeutics (STU:J4I) Total Liabilities: €1.59 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Solvonis Therapeutics Total Liabilities?

Solvonis Therapeutics STU:J4I Total Liabilities is €1.59 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Solvonis Therapeutics's Total Liabilities for the quarter that ended in Dec. 2025 was €1.59 Mil.

Solvonis Therapeutics's quarterly Total Liabilities increased from Dec. 2024 (€0.14 Mil) to Jun. 2025 (€3.07 Mil) but then declined from Jun. 2025 (€3.07 Mil) to Dec. 2025 (€1.59 Mil).

Solvonis Therapeutics's annual Total Liabilities declined from Dec. 2023 (€0.47 Mil) to Dec. 2024 (€0.14 Mil) but then increased from Dec. 2024 (€0.14 Mil) to Dec. 2025 (€1.59 Mil).

Solvonis Therapeutics Total Liabilities Historical Data

* Premium members only.

The historical data trend for Solvonis Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solvonis Therapeutics Total Liabilities Chart

Solvonis Therapeutics Annual Data
Trend May18 May19 May20 May21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 1.53 0.44 0.47 0.14 1.59

Solvonis Therapeutics Semi-Annual Data
May18 May19 May20 May21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.57 0.14 3.07 1.59

Solvonis Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Solvonis Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.549+(0.086+0.959
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.59

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=8.671-7.078
=1.59

Solvonis Therapeutics's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.549+(0.086+0.959
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.59

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=8.671-7.078
=1.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €1.59 Mil mean?
Solvonis Therapeutics (STU:J4I) has a Total Liabilities of €1.59 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Solvonis Therapeutics and its competitors.
Is Solvonis Therapeutics' Total Liabilities too high?
Solvonis Therapeutics' current Total Liabilities is €1.59 Mil.
How does Solvonis Therapeutics' Total Liabilities compare to GEV and ETN?
Solvonis Therapeutics' Total Liabilities of €1.59 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for an Industrial Products company?
A good Total Liabilities depends on the Industrial Products industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Solvonis Therapeutics and its competitors. Solvonis Therapeutics's current Total Liabilities is €1.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solvonis Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Solvonis Therapeutics (STU:J4I) is currently considered Possible Value Trap. The stock's GF Value™ is €0.02, compared to a current price of €0.00 — trading 95% below its estimated fair value. The current Total Liabilities is €1.59 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Solvonis Therapeutics (STU:J4I), the current Total Liabilities is €1.59 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Solvonis Therapeutics Business Description

Other Exchanges SVNS:UK
Address Eccleston Yards, 25 Eccleston Place, London, GBR, SW1W 9NF
Solvonis Therapeutics PLC focuses on the development of therapeutic solutions. The company is engaged in the development of novel small-molecule therapeutics for high-burden central nervous system ("CNS") disorders focusing on addiction and psychiatry. The products in company's pipeline include SVN-001, SVN-002, SVN-015. SVN-114, and others.